Transcript Dementia

Pamela Pride MD
December 3, 2009





Differentiate dementia from delirium and
depression
Recall the testing characteristics of screening
instruments
Differentiate different types of dementia
Recognize and manage caregiver stress
Demonstrate appropriately 3 screening
instruments to differentiate dementia,
delirium, and depression



Evidence from the history and mental status
examination that indicates major impairment in
learning and memory as well as at least one of
the following:
- Impairment in handling complex tasks
- Impairment in reasoning ability
- Impaired spatial ability and orientation
- Impaired language
It is progressive, usually incurable and
terminal





There are approximately 5.1 million Americans 65
years and older with dementia.
1 in 8 persons 65 and over
Nearly 50% of all persons over the age of 85 have
some type of dementia.
It is the sixth leading cause of death in the US
It is the third most expensive disease after
cardiovascular disease and cancer.
Alzheimer’s Association 2009 Facts and Figures
Projected numbers of demented
patients
16
Patients in millions
14
12
10
8
6
4
2
0
2000
2020
2040
2050
Signs of Dementia





Poor judgment and
decision making
Inability to manage a
budget
Losing track of the date or
the season
Difficulty having a
conversation
Misplacing things and
being unable to retrace
steps to find them
Alzheimer’s Association
Typical AgeRelated Changes





Making a bad decision
once in a while
Missing a monthly
payment
Forgetting which day it is
and remembering later
Sometimes forgetting
which word to use
Losing things from time to
time.
The 3 D’s
Depression - Dementia - Delirium
Delirium
Dementia
Depression
Onset
Abrupt
Slow, insidious
Recent, may be
associated with
loss
Duration
Hours to days
Months to years
Stable, may be
worse in the
morning
Attention
Impaired
Normal, except severe cases
Usually normal
Consciousness
Reduced,
fluctuating
Clear
Clear
Silverstein & Maslow, 2006
Dementia
Major Depression












Acute, nonprogressive
Depression
Affective before cognitive
Attention impaired
Orientation intact
Vocal memory complaint
Gives up on testing
Language intact
Patient complains
Better at night
Criticizes self
Self-referred












Insidious & progressive
Depression mild if present
Cognitive before affective
Recent memory impaired
Orientation impaired
Minimizes memory problem
Patient makes effort
Possibly aphasic
Family complains
Sundowning
Criticizes others
Referred by others
Antiparkinson drugs
Insomnia drugs
Corticosteroids
Narcotics
UI drugs
Theophylline
Emptying drugs (motility drugs) Muscle relaxants
Seizures Drugs
Cardiovascular Drugs
H2 blockers
Look to these medications
Antimicrobials
there is an ACUTE
NSAIDs
CHANGE IN MS
Geropsychiatric drugs
ENT drugs
http://www.geronurseonline.org;
Flaherty, J.H. (1998). Psychotherapeutic agents in older adults. Commonly prescribed and
over-the-counter remedies: causes of confusion. Clinics in Geriatric Medicine, 14(1): 101-27.
if
Antidepressants
Amitriptyline (Elavil®)
Clomipramine (Anafranil®)
Desipramine (Norpramin®)
Doxepine (Sinequan®)
Imipramine (Tofranil®)
Nortriptyline (Pamelor®)
Trazodone (Desyrel®)
Antidiarrheals
Diphenoxylate/Atropine (Lomotil®)
Antiemitics/Antivertigo
Dimenhydrinate (Dramamine®)
Meclizine (Antivert®)
Prochlorpromazine (Compazine®)
Promethazine (Phenergan®)
Scopolomine (Transerm-Scop®)
Antihistamines
Chlorpheniramine (Chlor-Trimeton®)
Cyproheptadine (Periactin®)
Diphenhydramine (Benadryl®)
Hydroxyzine (Vistaril/Atarax®)
Antiparkinsonian Agents
Benzotropine (Cogentin®)
Trihexyphenidyl (Artane®)
Antipsychotics
Chlorpromazine (Thorazine®)
Clozapine (Clozaril®)
Fluphenazine (Prolixin®)
Thioridazine (Mellaril®)
Triflupromazine (Stelazine®)
Gastrointestinal/Urinary Agents
Belladona alkaloids (Donnatol®)
Dicyclomine (Bentyl®)
Hyoscamine (Levsin®)
Oxybutinin (Ditropan®)
Muscle Relaxants
Carisoprodol (Soma®)
Cylobenzaprine (Flexeril®)
Orphenadrin (Norflex®)
Opiates




30 point maximum
<24 c/w impairment
Influenced by education
Does not distinguish dementia from delirium
Borson, S., et al (2000). Int J Geriatr Psych 15 (11): 1021-1027.
Clock Drawing Test
• Quick office-based
•
•
•
•
assessment tool
Brief (1-5 minutes)
Minimal language
requirement
Does not require
specialized testing
materials
Easily adapted for nonEnglish-speaking elderly
Sunderland T et al. (1989), J Am Geriatr Soc 37(8):725-729; Borson S et al. (1999), J Gerontol A Biol Sci Med Sci 54(11):M534-M540



Tests functional limitations/changes rather than
cognitive
Sensitivity and specificity comparable to the MMSE
Rating functional abilities over past 4 weeks
 Not applicable
 Normal
 Some difficulty but does by self
 Needs assistance
 Dependent
Pfeffer RI, et al. J Gerontol 37:323-329:1982










Writing checks, paying bills, balancing checkbooks
Assembling tax records, business affairs, or papers
Shopping alone for clothes, household necessities, or groceries
Playing a game of skill, working on a hobby
Heating water, making a cup of coffee, turning off stove
Preparing a balanced meal
Keeping track of current events
Paying attention to, understanding, discussing a TV show, book,
magazine
Remembering appointments, family occasions, holidays, medications
Traveling out of neighborhood, driving, arranging to take buses
Source: Pfeffer RI et al. J Gerontol. 1982;15:323-329.







Alzheimer’s Disease
Vascular Dementia (MID)
Lewy Body Dementia
Frontotemporal Dementia
PD
CJD
Secondary Causes
NHP
 Syphilis
 Thyroid dz
 B12 deficiency




Disease of old age, slight female predominance
Insidious and progressive memory impairment
Characteristic pattern of memory loss





Episodic→semantic→immediate recall→motor
Verbal, visual-spatial and subtle executive
function problems can be early signs
Apraxia, neuropsych sx and profound exec
function problems occur late in disease
Pts have poor insight
Neurologic exam normal early on

Various atypical forms exist







Posterior cortical atrophy
Primary progressive aphasia
Biparietal syndrome
Common to have AD and other dementia
Progressive, incurable and ultimately terminal
Mean survival 3-8 years
Death results from loss of motor memory





Cognitive dysfunction related to brain ischemia
Abrupt onset of symptoms followed by
stepwise deterioration
Executive func impairment early, memory later
Neuro exam and imaging c/w previous stroke
Risk factor modification and antiplatelet rx
recommended

Progressive cognitive decline







Usually executive func impaired prior to memory
Fluctuating cognition
Visual hallucinations
Spontaneous features of parkinsonism
Severe autonomic dysfunction
Neuroleptic sensitivity
Can mimic delirium


Earlier onset, more rapidly progressive
3 clinical variants
Behavioral variant
 Semantic dementia
 Progressive nonfluent aphasia





Parkinson’s related
CJD
Huntington’s disease
TBI







10-20% of pts labeled with dementia have
reversible causes
Of “true” dementias 5% are potentially
reversible
NPH most common
Hypothyroidism
B12 deficiency
Syphilis
SDH, cns neoplasms
Memory Concern Affecting
Daily Life
(Positive Screen)
Mini-Cog and Clock
Drawing Screen
Unclear or No Obvious Deficits
Cognitive Deficit Present
Consider Neuropsychological
Testing
Assess for Potentially
Reversible Causes:
•H & P and Neuro Exam
•History
•Laboratory Testing
•Medication Review
Potentially Reversible Condition
Present (including Depression &
Delirium)
Treat and Reassess
No Potentially Reversible
Condition Present
No or Partial Improvement
DEMENTIA

Cholinesterase inhibitors
Offer modest improvement in surrogate end points
for mild-mod disease
 Questionable cost benefit ratio
 Expected ADRs


Memantine


shows improvement in surrogate end points for
mod-severe disease
Appears safe, well tolerated

Managing behavioral sx
Aggression
 Wandering
 Physical and chemical restraints
 Co-morbid depression
 Is it ok to use neuroleptics?


Treating the family

Recognizing and managing caregiver stress
With any behavioral change it is important to evaluate for
underlying delirium and depression
 Wandering




Maintain and active daytime schedule
Re-orient frequently
Use alarm systems to keep pt safe
Aggression



Medically evaluate pt for delirium, pain, anxiety etc
Calming environment strategies
Carefully weigh risk:benefit with neuroleptics and discuss with
caregivers






Educate caregiver re: course of disease
Encourage HCPOA early and end of life preferences
Encourage Caregivers to find PCP’s and have routine
MD visits for themselves
Mobilize resources and make caregivers aware of
respite and day care services
Encourage caregivers to become familiar with NH’s
Encourage caregivers to stay with demented pt in
event of hospitalization

Evaluation & Diagnosis

Prognosis

Association Behavioral Symptoms

Safety Issues

Caregiver Stress

Community Resources
Over the past two weeks, how often
have you been bothered by any of
the following problems?
Little interest or pleasure in doing
things.
0 = Not at all
1 = Several days
2 = More than half the days
3 = Nearly every day
Feeling down, depressed, or hopeless.
0 = Not at all
1 = Several days
2 = More than half the days
3 = Nearly every day
Thibault,
PHQ-2 Score
Probability
of major
depressive
disorder (%)
Probability
of any
depressive
disorder (%)
1
15.4
36.9
2
21.1
48.3
3
38.4
75.0
4
45.5
81.2
5
56.4
84.6
6
78.6
92.9
JM, Prasaad Steiner, RW. (2004) “Efficient Identification of Adults
with Depression and Dementia.” American Family Physician (70):6.
1 = Acute Onset & Fluctuating Course
PLUS
2 = Inattention
AND EITHER
3 = Disorganized Thinking
OR
4 = Altered LOC (Most Common = Hypoactive)
Inouye et al. Ann Intern Med 1990
Falls
Strangulation
Loss of Muscle Tone
Pressure Sores
Decreased Mobility
Agitation
Reduced Bone Mass
Stiffness
Frustration
Loss of Dignity
Incontinence
Constipation
PLST/Environment
Progressively Lower Stress Threshold
•
•
•
•
•
•
Solutions
Avoid placing patient in a room with high noise
and traffic
Avoid room changes
Subdue physical environment
Be sensitive to amount of light
Remove threatening artwork
Use pictures and large words
Pt Admitted with Known or Suspected Dementia
CAM
Abnormal
Normal
Identify Underlying Cause of Delirium
and Treat
No Delirium
PHQ2 (If Possible)
Consistent with
Depression
Equivocal or Inconsistent
with Depression
Treat Depression or
Discuss Options
Mini-Cog
Impaired
Not Impaired
Re-Evaluate After
Treatment
No Action
Schedule Family Meeting
IF AT ANY TIME
PATIENT REQUIRES
PHYSICAL
RESTRAINTS,
DOCUMENT IN
CHART REASON
WHY AND NOTIFY
FAMILY
Discuss Dementia with Family
•Evaluation & Diagnosis
•Prognosis
•Associated Behavioral Symptoms
•Safety Issues
•Caregiver Stress
•Community Resources


Alzheimer’s Association St. Louis Chapter and
Washington University Alzheimer’s Disease
Research Center


Dementia-Friendly Hospitals: Care Not Crisis:
“Medical Overview: Recognition and Management
of Hospitalized Patients with Cognitive
Impairment.”
National Alzheimer’s Association “2009 Facts
and Figures”